Concepedia

A. Spagnoletti

AS

Statistics

Publications

5

Citations

99

H-Index

5

Active since

2022

Affiliations

Fondazione IRCCS Istituto Nazionale dei Tumori(Current)

Politecnico di Milano

University of Milan

University of Campania "Luigi Vanvitelli"

Istituti di Ricovero e Cura a Carattere Scientifico

A. Spagnoletti is an author at Fondazione IRCCS Istituto Nazionale dei Tumori specializing in cancer research, medicine, and cancer therapeutics.

ORCID

Top concepts

Publications per year

2022–2023

5

Publications

5

Cancer-related fatigue and depression: a monocentric, prospective, cross-sectional study in advanced solid tumors

Riccardo Lobefaro, Simone Rota, Luca Porcu et al. · ESMO Open · 2022 · 34 citations · Full text

Real-world data to build explainable trustworthy artificial intelligence models for prediction of immunotherapy efficacy in NSCLC patients

Arsela Prelaj, Edoardo Gregorio Galli, V. Miskovic et al. · Frontiers in Oncology · 2023 · 30 citations · Full text

PEOPLE (NTC03447678), a phase II trial to test pembrolizumab as first-line treatment in patients with advanced NSCLC with PD-L1 <50%: a multiomics analysis

Giuseppe Lo Russo, Arsela Prelaj, James M. Dolezal et al. · Journal for ImmunoTherapy of Cancer · 2023 · 14 citations · Full text

1689O Comprehensive mapping review of real-world evidence publications focusing on targeted therapies in solid tumors: A collaborative work from ESMO real-world data and Digital Health Working Group

Anna Pellat, Thomas Grinda, Arsela Prelaj et al. · Annals of Oncology · 2023 · 11 citations · Full text

, , +10

APOLLO 11 Project, Consortium in Advanced Lung Cancer Patients Treated With Innovative Therapies: Integration of Real-World Data and Translational Research

Arsela Prelaj, Monica Ganzinelli, Leonardo Provenzano et al. · Clinical Lung Cancer · 2023 · 10 citations · Full text

1–5 of 5